Space Coast residents gathered at Cocoa Riverfront Park on Saturday for the Alzheimer's Association Walk to End Alzheimer's, ...

Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease: New York Saturday, September 21, 2024, 14:00 Hrs [IST] Tiziana Life Sci ...

University of Arizona professor receives national award for breakthrough technology ...

Findings suggest that new genes can form by repurposing fragments of ancestral genes while incorporating entirely new coding regions (the protein-coding parts of the DNA). This innovative concept ...

LISBON, Sept. 20 (Xinhua) -- A team led by neuropharmacologist Maria Jose Diogenes has confirmed the therapeutic potential of a new compound for treating Alzheimer's, marking a major step in combating ...

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled ...

Staff at Citizens Memorial Hospital’s infusion center in Bolivar gave a patient kisunla this week. It’s the first health ...

Researchers at UCLA Health have discovered a molecule that shows promise in restoring memory and cognitive function in mice ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...

For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...

Hoth Therapeutics shares rose on Tuesday after the company said early clinical data of its therapeutic HT-ALZ suggested a potential "breakthrough" in the treatment of Alzheimer's disease. Shares in ...